Caplin Point Laboratories Limited (BOM:524742)
2,517.25
+1.15 (0.05%)
At close: Aug 31, 2026
Caplin Point Laboratories Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Caplin Point Laboratories stock has a consensus rating of "Strong Buy" and an average price target of ₹2,765. The average 1-year stock price forecast is 9.84% higher than the current stock price, while the lowest is ₹2,690 (+6.86%) and the highest is ₹2,840 (+12.82%).
Price Target: ₹2,765 (+9.84%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Caplin Point Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
25.07B
from 21.87B
Increased by 14.63%
Revenue Next Year
28.34B
from 25.07B
Increased by 13.03%
EPS This Year
95.60
from 84.11
Increased by 13.66%
EPS Next Year
110.70
from 95.60
Increased by 15.79%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.